Sandoz receives US FDA approval for long-acting oncology supportive care biosimilar Ziextenzo™ (pegfilgrastim-bmez)

    NEXT STORY
    Endoscope Market Poised to Exceed Over $28.4 Billion by 2024: P&S Intelligence
    PREV STORY
    Press Release Biocartis NV: Five Idylla™ Studies to be Published at ‘Association for Molecular Pathology’ Annual Meeting (US)
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Roxadustat Global Phase 3 Results for Treatment of Chronic Kidney Disease (CKD) Anemia to be Presented at American Society of Nephrology Kidney Week 2019

    author_avatar
    NASDAQ Market News

    Sanofi: ODYSSEY OUTCOMES investigators highlight at AHA that Praluent® (alirocumab) was associated with fewer deaths from any cause

    ODYSSEY OUTCOMES investigators highlight at AHA that Praluent® (alirocumab) was associated with fewer deaths ...

    author_avatar
    NASDAQ Market News

    Immunicum AB (publ) Announces Positive Phase II MERECA Topline Results Including Complete Tumor Responses in Metastatic Renal Cell Carcinoma Patients

    author_avatar
    NASDAQ Market News